Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
4.900
-1.840 (-27.30%)
At close: Dec 5, 2025, 4:00 PM EST
5.10
+0.20 (4.08%)
After-hours: Dec 5, 2025, 6:45 PM EST
Exicure Employees
Exicure had 7 employees as of December 31, 2024. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,318,429
Market Cap
31.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XCUR News
- 4 weeks ago - Exicure, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting - GlobeNewsWire
- 6 weeks ago - Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 2 months ago - Exicure Highlights Recent Achievements and Near-term Strategic Priorities - GlobeNewsWire
- 4 months ago - Exicure Posts Wider Loss in Fiscal Q2 - The Motley Fool
- 4 months ago - Exicure, Inc. Reports Second Quarter 2025 Financial Results - Business Wire
- 4 months ago - Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements - Business Wire
- 4 months ago - Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant - Business Wire